Tff Pharmaceuticals Correlations
TFFP Stock | USD 2.27 0.36 18.85% |
The current 90-days correlation between Tff Pharmaceuticals and Shattuck Labs is 0.15 (i.e., Average diversification). The correlation of Tff Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Tff Pharmaceuticals Correlation With Market
Weak diversification
The correlation between Tff Pharmaceuticals and DJI is 0.33 (i.e., Weak diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Tff Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
Tff |
Moving together with Tff Stock
Moving against Tff Stock
0.33 | ME | 23Andme Holding | PairCorr |
0.49 | VIRX | Viracta Therapeutics | PairCorr |
0.45 | SABSW | SAB Biotherapeutics | PairCorr |
0.41 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.34 | VRPX | Virpax Pharmaceuticals | PairCorr |
0.33 | SRZNW | Surrozen Warrant | PairCorr |
0.33 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.49 | EDSA | Edesa Biotech Fiscal Year End 20th of December 2024 | PairCorr |
0.37 | VYGR | Voyager Therapeutics | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Tff Stock performing well and Tff Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Tff Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
CYTK | 1.65 | (0.18) | 0.00 | (0.02) | 0.00 | 3.35 | 9.84 | |||
EWTX | 4.04 | 0.48 | 0.16 | 0.28 | 3.59 | 7.17 | 61.02 | |||
DYN | 2.79 | (0.44) | 0.00 | (0.10) | 0.00 | 5.27 | 35.97 | |||
THRD | 2.67 | (0.10) | (0.02) | 0.04 | 3.11 | 5.88 | 20.43 | |||
PMVP | 1.75 | (0.17) | 0.00 | (0.05) | 0.00 | 3.47 | 10.64 | |||
RVMD | 1.83 | 0.12 | 0.06 | 0.20 | 1.98 | 4.15 | 10.95 | |||
STTK | 4.98 | (1.44) | 0.00 | (0.25) | 0.00 | 9.00 | 54.53 | |||
ELYM | 4.08 | (0.25) | 0.00 | 1.60 | 0.00 | 9.09 | 34.87 | |||
CSBR | 2.89 | (0.20) | 0.00 | (0.06) | 0.00 | 5.76 | 21.23 | |||
IPSC | 4.60 | (1.02) | 0.00 | (0.15) | 0.00 | 11.51 | 30.97 |
Tff Pharmaceuticals Corporate Management
Harlan Weisman | Interim Chairman | Profile | |
Zamaneh MD | Chief Officer | Profile | |
Kirk Coleman | Treasurer CFO | Profile | |
Paul Manley | Head Affairs | Profile | |
Anthony Hickey | Chief Officer | Profile | |
Christopher Cano | COO Devel | Profile | |
Dale Christensen | Head Devel | Profile |